• BX Home
  • Drug Marketing: Blog [Page 5]

Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

DRUG MARKETING

Pharmaceutical companies are bombarding the airwaves with TV ads, showering doctors with gifts to get them to prescribe more of their drugs, and practicing other marketing tactics that can get them into hot water. The topic of drug marketing will examine the myriad ways the industry pushes its products -- and the inevitable controversies that result.

Drug Marketing is part of Business Exchange, suggested by Arlene Weintraub. This topic contains 443 news and 305 blog items. Read updated news, blogs, and resources about Drug Marketing. Find user-submitted articles and reactions on Drug Marketing from like-minded professionals.

Blogs

Recent blog posts on this topic.

Dr. Reddy's nears launch of Fujifilm venture, CFO saysmore

After announcing the tie-up almost a year ago, India's Dr. Reddy's Laboratories ($RDY) finally expects to ink a joint...

Valeant nabs Russia's Natur Produkt for $175M-plusmore

We sound like a broken record when it comes to Valeant Pharmaceuticals ($VRX): The Canadian drugmaker has made yet...

Takeda scouts for M&A in India, plots Chinese growthmore

India and China are on most expansion-minded drugmakers' shopping lists. So, it's not a huge surprise that top Japanese...

Dr. Reddy's eyes acquisitions in Russiamore

India's Dr. Reddy's Laboratories plans to go shopping in Russia. The generics specialist wants to expand its portfolio...

Pfizer Cuts Jobs In Germany: Is It Payback?more

There is certainly nothing surprising that Pfizer or any other large drugmaker is planning to cut jobs.

J&J's Scios to plead guilty, pay $85M in Natrecor casemore

Johnson & Johnson's ($JNJ) legion of legal problems is one less strong. The company agreed to pay $85 million and...

Pharmalot… Pharmalittle… Good Morningmore

Top of the morning to you. We have just returned from one of the local schoolhouses, where we have deposited a sleepy...

Aspen Pharmacare eyes another $800M in M&Amore

South Africa's Aspen Pharmacare has posted some strong full-year sales and profits growth, thanks in part to expansion...

Newer Drugs Must Be Better, Right?more

Is this surprising? A new study finds that 39 percent of the public mistakenly believes that the FDA approves only...

Dems Press FTC On Express Scripts-Medco Dealmore

Three Democratic members of the US House are pressing the US Federal Trade Commission to conduct an in-depth analysis...

J&J investor demands that CEO give up millions in paymore

Johnson & Johnson ($JNJ) CEO Bill Weldon (photo) is the highest-paid Big Pharma chief, no question. His $28.

Biogen takes European MS marketing in-house with JV buyoutsmore

Biogen Idec ($BIIB) is taking its multiple sclerosis marketing in house. The Massachusetts-based company has bought out...

Lilly in partnership talks with Turkey's MN Pharmamore

Emerging markets continue to beckon Big Pharma. Eli Lilly ($LLY) is in partnership talks with Turkey's Mustafa Nevzat...

Pfizer’s Lipitor Webpage Is Slammed By FDAmore

Once again, a web page is deemed problematic by the FDA. In a letter sent by the agency earlier this week, Pfizer was...

FTC report IDs new twist on pay-to-delaymore

The Federal Trade Commission has found a new target in its quest to foster competition in the drug market: authorized...

Piramal to invest $1.5B in ex-India pharmamore

Piramal's generics excitement in India was only the first step in becoming a "major player" in global pharma.

Pharma reps swarm Indian docs' officesmore

It's no secret drugmakers have been hiring sales reps by the dozen in emerging markets. As sales in mature markets...

Cipla eyes alliances to grow in emerging marketsmore

Takeda may well be eyeing a buyout to expand in India, but Cipla, one of its supposed targets, has its own emerging...

In India, Drug Reps Get 20 Seconds With A Docmore

Remember how side effects of a prescription med were read so quickly in television ads that it was impossible to...

AZ: No more free trips for doctorsmore

AstraZeneca CEO David Brennan (photo) announced at a conference in Istanbul that his company will no longer foot the...

GSK chief: Emerging markets sales do the jobmore

GlaxoSmithKline CEO Andrew Witty (photo) says the company's emerging-markets strategy is working. In an interview with...

Pharmalot… Pharmalittle… Good Morningmore

Hello, everyone, and welcome to the working week. Another overcast day is unfolding here on the Pharmalot corproate...

Takeda snaps up Nycomed in $13.6B dealmore

Word on the street proved true today; Takeda Pharmaceutical announced it had agreed to buy Nycomed for almost $14...

Can Merck/Roche hep C deal put Victrelis combo on top?more

What's better than Big Pharma marketing power? Big Pharma marketing power times two. Merck has tapped Roche to help...

Generics, emerging markets to take over pharma growthmore

New projections for global drug sales look pretty for generics makers--but not so pretty for brands. The growth in...

Top Sources: Drug Marketing

  • News
  • medicinesocialjustice.blogspot.com
  • blogs.nature.com
  • carlatpsychiatry.blogspot.com
  • doseofdigital.com
  • drugreptoys.blogspot.com
  • cfpie.com
  • Pharmalot
  • CNBC
  • eyeonfda.com

Most Active Users in this Topic

see all contributors in Drug Marketing

Featured White Papers

Post a Job

Jobs in this Topic

Process Sciences Associate Drug Product Regeneron | Rensselaer, NY
Posted: Jun 14
Marketing Director-Assisted Living Job HCR Manor Care | King of Prussia, PA
Posted: Jun 12
Lead Analyst Pharma Sales / Marketing Analytics Group Technology | Swiftwater, PA
Posted: Apr 27
Prescription Drug Monitoring Account Executive Quest Diagnostics | Las Vegas, NV
Posted: Jun 3

Report comment contains invalid characters. ()
cancel
Search Cancel